Cahill Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $383K | Hold |
727
| – | – | 0.04% | 218 |
|
|
2026
Q1 | $408K | Sell |
727
-1
| -0.1% | -$641 | 0.04% | 200 |
|
|
2025
Q4 | $493K | Sell |
728
-15
| -2% | -$10.2K | 0.05% | 176 |
|
|
2025
Q3 | $475K | Buy |
743
+10
| +1% | +$6.07K | 0.05% | 181 |
|
|
2025
Q2 | $393K | Hold |
733
| – | – | 0.05% | 198 |
|
|
2025
Q1 | $308K | Sell |
733
-25
| -3% | -$10.9K | 0.04% | 214 |
|
|
2024
Q4 | $313K | Hold |
758
| – | – | 0.04% | 214 |
|
|
2024
Q3 | $383K | Sell |
758
-5
| -0.7% | -$2.43K | 0.05% | 186 |
|
|
2024
Q2 | $372K | Buy |
763
+3
| +0.4% | +$1.51K | 0.05% | 193 |
|
|
2024
Q1 | $410K | Buy |
760
+26
| +4% | +$14.2K | 0.06% | 188 |
|
|
2023
Q4 | $407K | Buy |
734
+1
| +0.1% | +$469 | 0.06% | 176 |
|
|
2023
Q3 | $321K | Buy |
733
+129
| +21% | +$64.3K | 0.05% | 185 |
|
|
2023
Q2 | $303K | Buy |
604
+1
| +0.2% | +$479 | 0.05% | 195 |
|
|
2023
Q1 | $302K | Hold |
603
| – | – | 0.05% | 194 |
|
|
2022
Q4 | $246K | Buy |
+603
| New | +$234K | 0.05% | 204 |
|
|
2022
Q3 | – | Sell |
-600
| Closed | -$210K | – | 218 |
|
|
2022
Q2 | $210K | Buy |
600
+1
| +0.2% | +$408 | 0.04% | 203 |
|
|
2022
Q1 | $328K | Hold |
599
| – | – | 0.06% | 180 |
|
|
2021
Q4 | $394K | Hold |
599
| – | – | 0.08% | 173 |
|
|
2021
Q3 | $373K | Hold |
599
| – | – | 0.08% | 172 |
|
|
2021
Q2 | $378K | Hold |
599
| – | – | 0.09% | 161 |
|
|
2021
Q1 | $293K | Sell |
599
-156
| -21% | -$78.2K | 0.07% | 174 |
|
|
2020
Q4 | $377K | Hold |
755
| – | – | 0.1% | 148 |
|
|
2020
Q3 | $297K | Sell |
755
-149
| -16% | -$55.1K | 0.11% | 132 |
|
|
2020
Q2 | $299K | Hold |
904
| – | – | 0.12% | 131 |
|
|
2020
Q1 | $219K | Hold |
904
| – | – | 0.1% | 139 |
|
|
2019
Q4 | $237K | Sell |
904
-231
| -20% | -$60.9K | 0.09% | 146 |
|
|
2019
Q3 | $309K | Hold |
1,135
| – | – | 0.12% | 131 |
|
|
2019
Q2 | $313K | Hold |
1,135
| – | – | 0.12% | 122 |
|
|
2019
Q1 | $254K | Hold |
1,135
| – | – | 0.11% | 140 |
|
|
2018
Q4 | $212K | Hold |
1,135
| – | – | 0.11% | 140 |
|
|
2018
Q3 | $284K | Hold |
1,135
| – | – | 0.13% | 129 |
|
|
2018
Q2 | $248K | Hold |
1,135
| – | – | 0.11% | 136 |
|
|
2018
Q1 | $218K | Sell |
1,135
-165
| -13% | -$30.5K | 0.1% | 139 |
|
|
2017
Q4 | $204K | Hold |
1,300
| – | – | 0.1% | 135 |
|
|
2017
Q3 | $203K | Hold |
1,300
| – | – | 0.11% | 134 |
|
|
2017
Q2 | $210K | Hold |
1,300
| – | – | 0.12% | 134 |
|
|
2017
Q1 | $201K | Buy |
+1,300
| New | +$179K | 0.12% | 127 |
|
Other funds holding IDXX
Cahill Financial Advisors's IDXX Position: Q2 2026 in Review
Cahill Financial Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 727 shares worth $383K. The position accounts for 0.04% of the portfolio, ranked #218.
Cahill Financial Advisors first reported a position in IDXX in Q1 2017 and has held it in 37 quarters since. The position peaked at $493K in Q4 2025. 891 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Cahill Financial Advisors held 727 shares of Idexx Laboratories worth $383K as of Q2 2026.
- Cahill Financial Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.04% of Cahill Financial Advisors's portfolio in Q2 2026, its #218 holding.
- Cahill Financial Advisors first reported a position in Idexx Laboratories in Q1 2017 and has held it in 37 quarters since.
- Cahill Financial Advisors's Idexx Laboratories position peaked at $493K in Q4 2025.
- 891 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Cahill Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.